Global News Distribution

drugs

Americans Hunt for Certified Canadian Online Pharmacies to Avoid Rogue Pharmacies

May 19, 2021 (Global News Distribution) -

It’s always important to make an informed decision where you get your medication. While convenient, many online pharmacies are considered “Rogue pharmacies” that may not provide safe and effective medication.

Your Canada Drug Store has 20 years of combined experience in the online pharmacy industry. They work hard to ensure that safe and effective medication can be affordable for the people that need it. They provide these tips to ensure that you are working with a legitimate and trustworthy online pharmacy.

1: Make sure it approved by CIPA and Pharmacychecker

Objective Third-party organizations are important to ensure you’re getting objective information about companies. CIPA and pharmacy checkers monitor online pharmacies to ensure that they comply with all the rules and regulations of the industry. A seal of approval by BOTH of these companies will ensure that you are working with a quality website.

2: Never order from a pharmacy that does not require a prescription.

Selling prescription drugs without a medical prescription is illegal. While it is sometimes difficult or costly to see a doctor, it is a prerequisite to find a legitimate source of the medication. If an online pharmacy is willing to send a medication without the proper documents, they will likely not follow safety guidelines or send a quality product.

While it may be tempting to take the easy route, your pharmacy should do its best to protect your health. If a website follows the proper guidelines of an online pharmacy, that is a good sign they are trustworthy.

3: Check that the website has encryption technology to protect your information.

While this may not be obvious to most people, website security should be a major concern. You likely need to provide personal, medical, and financial information to the website. While there are indications on the URL, they should provide their web severity credentials prominently on the front page. SSL encryption is the standard. You should also check the website’s privacy policy to ensure that they specify their personal information policy.

4: Ensure they have a pharmacist available for counseling

While many individuals are well educated on how to take their medicine, always check to make sure you can speak to a pharmacist when necessary. Online pharmacies have an obligation to ensure patients can use their medication properly and are cognizant of any potential risks. A website that will offer a medication without a licensed pharmacist on staff is likely willing to compromise your health.

5: Only order from a website that indicates where the medicine comes from

Most online pharmacies offer medication from around the world. Some individuals have preferences on where their medication comes from. Products from Canada and the U.K are often preferred even if they cost more.

There can be affordable and safe options from India and Turkey. Even if you do not have a specific preference in favor of the best prices, make sure that you are at least aware of where your products are dispensed from.

Pharmacies that are not transparent about this may be sourcing counterfeit medication from other countries. When an online pharmacy includes the country of origin, it confirms they have a relationship with that pharmacy and they are a reliable source of medication.

A website that does not properly evaluate its dispensing pharmacy partners may get their medicine from regulated supply chains. It may not be safe or effective.

6: Look at the reviews online

Customer reviews are a prediction of your potential experience with those companies. Everyone’s opinion should matter.

Companies that do not have a third-party review service may be trying to hide something. A successful and customer-focused Prescription drugs company should have mostly 5-staMedia Contactr reviews. People provide reviews of their own volition and as long as an objective third party service is hosting the review, they can work to inform you if people are happy using a service.

7: Make sure they guarantee their products

Even if you have taken painstaking care in choosing an online pharmacy, sometimes mistakes can happen. Occasionally things may get lost in the mail, or someone may make a mistake. When these things happen, the pharmacy should have a robust return policy or money-back guarantee. Online pharmacies that do not have a return guarantee do not trust their products and will not assist you when something happens that is out of your control. You should not take a risk when you order medicine online. Always review the website’s return policy to ensure they are reliable.

Finding a pharmacy that is genuinely concerned about your safety and well-being. According to the CDC, 1 in 10 Americans needs to ration their medicine and skip doses due to high drug costs. Once you have established a relationship with a professional online pharmacy, it should help manage your therapeutic drug plan.

Media Contact

Your Canada Drug Store
info@ycdscc.com
1-844-416-4282
https://ycdscc.com/

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

American Screening LLC on Improved Efficiency in Decision-Making with Rapid Drug Tests

May 6, 2021 (Global News Distribution) -

Despite the social progress and economic prosperity achieved in the past few decades, certain issues remain a common challenge for nations worldwide. One of them is illicit drug use, which has been straining healthcare budgets, affecting workplace productivity, and endangering public safety. However, medical and technological advances have enabled government agencies, healthcare professionals, employers, and individuals to make progress in the fight against substance abuse and its broader consequences. As Ron Kilgarlin, Founder of American Screening LLC, can attest, rapid drug tests have become one of the most useful diagnostic tools in modern society, providing fast and accurate results that often save lives or enhance business results by improving the decision-making process. American Screening LLC, a leading ISO13485 contract manufacturer and distributor of diagnostic products and essential medical supplies, maintains a robust inventory of rapid drug testing kits to help public organizations, corporate entities, and regular citizens act quickly and minimize the risk of any substance abuse-related problems escalating.

From its inception, the company has been committed to offering products of the highest quality at affordable prices along with supporting efforts to combat drug addiction. “Even though we have grown to become a major organization with operations across the globe, our core mission has remained the same, and a key part of it is providing cost-effective and efficient solutions for addressing this grave problem. Our inventory is constantly expanding, but we have made it a priority to always have in stock a vast array of rapid drug tests due to our realization of how important these products are,” American Screening LLC comments. “Whether in the workplace, at home, or in law enforcement settings, these kits are becoming indispensable as illicit substance use increases. Our extensive range features tests that can detect from one to as many as 12 drugs of abuse with accuracy of up to 99%. They make it easy to check for the presence of the most commonly used drugs, including marijuana, cocaine, fentanyl, oxycodone, opiates, methamphetamine, amphetamines, K2, ETG, phencyclidine (PCP), benzodiazepine, barbiturates, methadone, and ecstasy (MDMA).”

The importance of rapid drug tests is underscored by the fact that this segment of the drug abuse testing market is expected to register the strongest growth in the years ahead, American Screening LLC notes. According to Allied Market Research, total industry revenues will rise by 8.2% annually from 2017 to 2025, increasing from $6.24 billion to $11.83 billion over the specified period. Notably, the report projects a compound annual growth rate of 14.2% for the rapid testing products segment “owing to its benefits such as accuracy in results in less time and advent of technologically advanced devices.” For American Screening LLC, providing a rich choice of rapid drug tests is a way to ensure optimal outcomes for all parties concerned, be it in emergency medical settings, corporate environments, or public places. Its products empower healthcare professionals, law enforcement officers, employers, and family members to make the right decisions and act quickly, thus preventing or rectifying situations with potentially fatal consequences.

American Screening LLC started in a small room in Shreveport, Louisiana as a family business on a mission to provide quality drug and alcohol testing products. Since its launch in 2004, the company has expanded steadily to become a top vendor of diagnostic tests and essential medical supplies to the United States, South America, Asia, Africa, Europe, and Australia. Much of its success is attributable to the founder, Ron Kilgarlin, who drew on his extensive expertise in business management, medical devices, product development, distribution, and marketing. Among the many things American Screening LLC takes pride in are its multiple certifications, including the highly coveted one issued under MDSAP (Medical Device Single Audit Program), which designates the company as compliant with the requirements for quality management systems in multiple jurisdictions.

American Screening, LLC – Leading Provider of Diagnostic Tests & Medical Supplies: http://americanscreeningcorporationnews.com

American Screening, LLC Now Offers COVID-19 Antibody Rapid Serology Tests: https://www.biospace.com/article/releases/american-screening-llc-now-offers-covid-19-antibody-rapid-serology-tests/

Contact Information:

Ron Kilgarlin
American Screening, LLC
9742 St Vincent Ave, Ste 100
Shreveport, LA 71106
1-866-526-2873
sales@americansreeningcorp.com
https://www.americanscreeningcorp.com

SOURCE: American Screening LLC

For more latest News

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier

May 4, 2021 (Global News Distribution) -

First-of-its-kind software predicts likelihood of off-target safety issues that could impede clinical progress

Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of its Secondary Intelligence™ software, the first and only software that quantitatively predicts the risk of adverse effects and safety issues derived from secondary pharmacology that may impede the clinical development of a drug.

Safety issues account for approximately one-quarter of candidate attrition in drug development projects. They can arise from either intended or unintended drug-receptor interactions, also known as primary or secondary pharmacology, respectively. Secondary pharmacological profiling is increasingly applied by drug developers and assessed by regulators to evaluate the potential of off-target effects of novel drugs. To address secondary pharmacology, researchers typically screen their small molecule compounds against a broad panel of off-target receptors. The challenge is interpreting the readouts to understand which receptor interactions will contribute to potential adverse effects in clinical development and post-marketing.

“While drug developers and regulators rely on secondary pharmacology analyses to support critical development decisions, the current process is inefficient, inconsistent, and often imprecise,” said William F. Feehery, Ph.D., CEO of Certara. “With our Secondary Intelligence software, drug developers will be able to make faster, more confident go/no go portfolio decisions earlier in the drug discovery and development process which will help to increase the likelihood of success in clinical trials.”

Certara’s Secondary Intelligence software is the only software that curates and visualizes secondary pharmacology analyses to evaluate safety liabilities against multiple receptors. It ranks the likelihood of off-target interaction during clinical use to make critical decisions on which compounds to progress or modify.

“We have unlocked the potential of secondary pharmacology data to provide automated intelligence so that safety pharmacologists and toxicologists can more confidently and consistently predict the off-target safety risks associated with their compounds faster and earlier,” said Will Redfern, Ph.D., Vice President, Quantitative Systems Toxicology & Safety at Certara. “Secondary Intelligence allows drug developers to de-risk their programs with evidence-based secondary pharmacology insights, which could save significant time, cost, and resources further down the line.”

To learn more about the Secondary Intelligence software and consulting services, please visit: https://www.certara.com/services/quantitative-systems-toxicology-safety/.

About Certara 

Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.

Certara Contact
Jieun W. Choe
jieun.choe@certara.com

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Elizabeth Tang, Ph.D.
Finn Partners
elizabeth.tang@finnpartners.com

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

United States Systemic Lupus Erythematosus Market and Competitive Landscape Report 2021-2026 – ResearchAndMarkets.com

February 3, 2021 (Global News Distribution) -

The latest research US Systemic Lupus Erythematosus Market and Competitive Landscape Highlights – 2021, provides comprehensive insights into Systemic Lupus Erythematosus pipeline products, Systemic Lupus Erythematosus epidemiology, Systemic Lupus Erythematosus market valuations and forecast, Systemic Lupus Erythematosus drugs sales and competitive landscape in the US.

The research is classified into seven sections – Systemic Lupus Erythematosus treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:

  • Systemic Lupus Erythematosus pipeline: Find out the products in clinical trials for the treatment of Systemic Lupus Erythematosus by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Systemic Lupus Erythematosus epidemiology: Find out the number of patients diagnosed (prevalence) with Systemic Lupus Erythematosus in the US
  • Systemic Lupus Erythematosus drugs: Identify key products marketed and prescribed for Systemic Lupus Erythematosus in the US, including trade name, molecule name, and company
  • Systemic Lupus Erythematosus drugs sales: Find out the sales revenues of Systemic Lupus Erythematosus drugs in the US
  • Systemic Lupus Erythematosus market valuations: Find out the market size for Systemic Lupus Erythematosus drugs in 2019 in the US. Find out how the market advanced from 2017 and forecast to 2026
  • Systemic Lupus Erythematosus drugs market share: Find out the market shares for key Systemic Lupus Erythematosus drugs in the US

Benefits of this Research:

  • Support monitoring and reporting national Systemic Lupus Erythematosus market analysis and sales trends
  • Track competitor drugs sales and market share in the US Systemic Lupus Erythematosus market
  • Track competitive developments in Systemic Lupus Erythematosus market and present key issues and learnings
  • Synthesize insights for Systemic Lupus Erythematosus market and products to drive business performance
  • Answer key business questions about the Systemic Lupus Erythematosus market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Systemic Lupus Erythematosus products
  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1) Systemic Lupus Erythematosus Treatments

2) Systemic Lupus Erythematosus Pipeline

3) US Systemic Lupus Erythematosus Epidemiology

4) Marketed Drugs for Systemic Lupus Erythematosus in US

5) US Systemic Lupus Erythematosus Market Size and Forecast

6) US Systemic Lupus Erythematosus Products Sales and Forecast

7) US Systemic Lupus Erythematosus Market Competitive Landscape

8) Methodology

For more information about this report visit https://www.researchandmarkets.com/r/54ryt9

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

United Recovery Project Founder Hosts Hit Addiction & Recovery Podcast: Hell Has an Exit

February 2, 2021 (Global News Distribution) -

Hell Has an Exit is the new hit addiction & recovery podcast. Host Bryan Alzate honors the resilience of the human spirit by interviewing those who have fought the fight to find their exit from the depths of Hell – emotionally raw, vulnerable and uncut.

At 14, host Bryan Alzate found himself addicted to crack and Oxycontin. At 17, he found his exit out of Hell by getting clean and through his involvement in the 12 step program. Today Bryan is CEO and Founder of United Recovery Project, a drug rehabilitation center located in Florida. He dedicates the majority of his life to helping others find the exit.

The podcast dives deep into the desperate journey of an addict, interviewing individuals who have dealt with addiction.

The show covers a variety of addiction-related topics, such as:

Experimenting with drugs
Addictive personalities
The disease of addiction
The effect addiction has on families
Overcoming addiction
Mental health awareness
Ending the stigma behind addiction
Using and selling drugs since a young age
The journey of addiction
Crimes committed in active addiction
Forgiving yourself and others
Self-honesty and desperation
Goal setting and taking your life back
Factors of getting clean
Joining treatment while in jail
Living a life beyond your wildest dreams
Reconnecting with family
The miracle of recovery

This podcast will take you for a wild ride down the road to recovery. Episodes range all the way from stories of the son of a Colombian cartel boss doing cocaine at 12, to a drug addicted gangbanger selling kilos of cocaine who now has 9 years clean and multiple college degrees, to a cheerleader addicted to heroin obtaining her Master’s degree and being a present and loving mother. And while the podcast’s main focus is addiction, some episodes feature people exiting different kinds of “Hell”. In one episode, Bryan sits down with Anita Karl, as she tells her story of being one of the youngest survivors of the Holocaust (among 200 of 150,000 to survive), watching her cousin being murdered 5 feet in front of her over a chocolate bar, and preparing for the impossible escape.

Filled with twists, turns, and heartaches, Hell has an Exit also provides a glimmer of hope at the end of the tunnel. The podcast is available on Apple, YouTube, Spotify, Google Podcasts, SoundCloud, and iHeart Radio. Whether you’re on your recovery journey, or are looking for inspiration, Hell has an exit.

Contact Author: MARIA ARREDONDO

United Recovery Project
+1 3056009204

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection